Phil Hamzik helps clients build and manage US and international patent portfolios in the areas of pharmaceuticals and biotechnology. He has secured comprehensive patent protection on behalf of clients, including patents to compound libraries, clinical stage candidates, formulations, combination therapies and synthetic methods. Phil has extensive knowledge and experience in the areas of medicinal chemistry and drug discovery, organic synthesis, polymer chemistry, polypeptide and oligonucleotide therapeutics, and more.

Phil works with a diverse range of clients, including small to large pharmaceutical and biotechnology companies, universities, and research institutes. In addition to patent application drafting and prosecution, he provides clients with strategic advice and assists with patentability, freedom-to-operate and due diligence work.

Prior to joining Wolf Greenfield, Phil obtained his PhD in Organic Chemistry from the Massachusetts Institute of Technology. His doctoral research focused on the development of new cycloaddition strategies for the synthesis of highly substituted nitrogen heterocycles. Phil completed his undergraduate studies at Northeastern University, where he obtained a BS in Chemistry and Philosophy. 

Phil also brings industry experience to his practice, having worked for two leading pharmaceutical companies. As an intern at Merck Research Laboratories in Boston, Phil developed new synthetic methods for the preparation of important molecular scaffolds. At Novartis Institutes for BioMedical Research in Cambridge, he worked as a medicinal chemistry intern in the area of infectious diseases.

  • Prepared and prosecuted US and foreign patent applications relating to a wide range of technologies in the pharmaceutical and biotechnology spaces
  • Assisted clients in managing large global patent portfolios, including those covering clinical stage drug candidates
  • Conducted patentability and freedom-to-operate analyses and advised clients regarding same; assisted with due diligence reviews of complex patent portfolios
  • Boston Patent Law Association (BPLA)
  • Massachusetts LGBTQ Bar Association
  • Suffolk University Law School Recognition for Outstanding Performance in Legal Writing
  • MIT Department of Chemistry Award for Continued Excellence in Teaching
  • American Chemical Society POLYED Award for Outstanding Achievement in Organic Chemistry
  • Northeastern University Excellence in Writing Award

Blogs

April 8, 2021

The Federal Circuit Adds Color to Formulation Claims in Olaplex v. L’Oréal

January 17, 2018

Proving Them Wrong: FDA Skepticism Helps Save Patent Claims



Scientific Publications

  • Bartko, S. G.; Hamzik, P. J.; Espindola, L.; Gomez, C.; Danheiser, R. L. “Synthesis of Highly Substituted Pyridines via [4+2] Cycloadditions of Vinylallenes and Sulfonyl Cyanides” J. Org. Chem. 2020, 85, 548-563
  • Sasaki, M.; Hamzik, P. J.; Ikemoto, H.; Bartko, S. G.; Danheiser, R. L. “Formal Bimolecular [2 + 2 + 2] Cycloaddition Strategy for the Synthesis of Pyridines: Intramolecular Propargylic Ene Reaction/Aza Diels–Alder Reaction Cascades” Org. Lett. 2018, 20, 6244−6249
  • Hamzik, P. J.; Hautecloque, A.-S.; Sakai, T.; Danheiser, R. L. “Aza Diels–Alder Reactions of Nitriles, N,N-Dimethylhydrazones, and Oximino Ethers. Application in Formal [2 + 2 + 2] Cycloadditions for the Synthesis of Pyridines” J. Org. Chem. 2017, 82, 12975-12991
  • Hamzik, P. J.; Brubaker, J. D. “Reactions of Oxetan-3-tert-butylsulfinimine for the Preparation of Substituted 3-Aminooxetanes” Org. Lett. 2010, 12, 1116–1119


Expand All

Phil Hamzik helps clients build and manage US and international patent portfolios in the areas of pharmaceuticals and biotechnology. He has secured comprehensive patent protection on behalf of clients, including patents to compound libraries, clinical stage candidates, formulations, combination therapies and synthetic methods. Phil has extensive knowledge and experience in the areas of medicinal chemistry and drug discovery, organic synthesis, polymer chemistry, polypeptide and oligonucleotide therapeutics, and more.

Phil works with a diverse range of clients, including small to large pharmaceutical and biotechnology companies, universities, and research institutes. In addition to patent application drafting and prosecution, he provides clients with strategic advice and assists with patentability, freedom-to-operate and due diligence work.

Prior to joining Wolf Greenfield, Phil obtained his PhD in Organic Chemistry from the Massachusetts Institute of Technology. His doctoral research focused on the development of new cycloaddition strategies for the synthesis of highly substituted nitrogen heterocycles. Phil completed his undergraduate studies at Northeastern University, where he obtained a BS in Chemistry and Philosophy. 

Phil also brings industry experience to his practice, having worked for two leading pharmaceutical companies. As an intern at Merck Research Laboratories in Boston, Phil developed new synthetic methods for the preparation of important molecular scaffolds. At Novartis Institutes for BioMedical Research in Cambridge, he worked as a medicinal chemistry intern in the area of infectious diseases.

  • Prepared and prosecuted US and foreign patent applications relating to a wide range of technologies in the pharmaceutical and biotechnology spaces
  • Assisted clients in managing large global patent portfolios, including those covering clinical stage drug candidates
  • Conducted patentability and freedom-to-operate analyses and advised clients regarding same; assisted with due diligence reviews of complex patent portfolios
  • Boston Patent Law Association (BPLA)
  • Massachusetts LGBTQ Bar Association
  • Suffolk University Law School Recognition for Outstanding Performance in Legal Writing
  • MIT Department of Chemistry Award for Continued Excellence in Teaching
  • American Chemical Society POLYED Award for Outstanding Achievement in Organic Chemistry
  • Northeastern University Excellence in Writing Award

Scientific Publications

  • Bartko, S. G.; Hamzik, P. J.; Espindola, L.; Gomez, C.; Danheiser, R. L. “Synthesis of Highly Substituted Pyridines via [4+2] Cycloadditions of Vinylallenes and Sulfonyl Cyanides” J. Org. Chem. 2020, 85, 548-563
  • Sasaki, M.; Hamzik, P. J.; Ikemoto, H.; Bartko, S. G.; Danheiser, R. L. “Formal Bimolecular [2 + 2 + 2] Cycloaddition Strategy for the Synthesis of Pyridines: Intramolecular Propargylic Ene Reaction/Aza Diels–Alder Reaction Cascades” Org. Lett. 2018, 20, 6244−6249
  • Hamzik, P. J.; Hautecloque, A.-S.; Sakai, T.; Danheiser, R. L. “Aza Diels–Alder Reactions of Nitriles, N,N-Dimethylhydrazones, and Oximino Ethers. Application in Formal [2 + 2 + 2] Cycloadditions for the Synthesis of Pyridines” J. Org. Chem. 2017, 82, 12975-12991
  • Hamzik, P. J.; Brubaker, J. D. “Reactions of Oxetan-3-tert-butylsulfinimine for the Preparation of Substituted 3-Aminooxetanes” Org. Lett. 2010, 12, 1116–1119

Blogs

April 8, 2021

The Federal Circuit Adds Color to Formulation Claims in Olaplex v. L’Oréal

January 17, 2018

Proving Them Wrong: FDA Skepticism Helps Save Patent Claims